Quadrille Capital
Dr François Thomas has 30 years of experience in the life sciences sector. He has been the president of Inserm Transfert Initiative. Previously, he held senior management positions at Bioserve, Ipsen, Genset, Bryan Garnier and was a Partner at Atlas Venture. He has been on the board of directors of more than 20 Biotech companies. Dr. Thomas is an oncologist, former physician at Gustave Roussy, and holds an MBA from MIT
This person is not in any offices
Quadrille Capital
Quadrille Capital is a Paris-based Private Equity and Venture Capital firm established in 2001, investing globally in high-growth technology and healthcare companies backed by leading Venture Capital and Growth Equity funds. The firm has $1bn of Assets under Management. Through its unique investment strategy and collaborative approach, Quadrille Capital is able to partner with the best-performing Tech and Healthcare funds to access direct investments in some of the world’s most exciting growth companies. With a team in Paris and San Francisco, Quadrille Capital has carried out some 40 direct investments in companies and 30+ commitments to funds. These are spread across the Western US, Eastern US, Europe, and Asia.